Stacking on Sermorelin: getting it right

A reader on r/Peptides asked whether stacking tirzepatide with sermorelin could slow or reverse the weight loss from the tirzepatide alone. Short answer: sermorelin stacking with a GLP-1 does not slow fat loss, but it does change how you need to time the sermorelin dose, and getting that timing wrong is the actual mistake people make.

I get versions of this question constantly from people running a GH-axis peptide alongside a GLP-1, and the worry usually comes from the same place: growth hormone raises blood sugar a little and can nudge insulin resistance in high, sustained doses, so people assume anything that touches GH must be fighting against a fat-loss drug. That is not how sermorelin works. It does not inject growth hormone into you. It asks your own pituitary to release a pulse of GH that your body already makes, at a level your feedback loop still controls. Tirzepatide, meanwhile, works through GLP-1 and GIP receptors to slow gastric emptying, cut appetite, and improve insulin sensitivity. Those are two different systems doing two different jobs, and nothing in the human data on either compound points to one canceling the other out.

Why the two don't actually compete

Sermorelin is GHRH(1-29), the working fragment of your own growth-hormone-releasing hormone. You can read the full mechanism on the sermorelin encyclopedia page, but the short version matters here: it binds the GHRH receptor on your pituitary, triggers a short calcium and cyclic-AMP cascade, and your pituitary releases a pulse of GH that your body's own somatostatin brake still regulates. That pulse-preserving design is exactly why sermorelin has real human trial data behind it. The pediatric GH-deficiency trials and the larger open-label study that became part of its FDA dossier showed it reliably drives measurable GH-dependent growth in people, which is a stronger evidence base than most peptides in this space get to claim.

None of that mechanism touches appetite, gastric emptying, or insulin signaling the way tirzepatide does. A modest GH pulse at night is not going to override the receptor-level appetite suppression a GLP-1/GIP drug produces during the day. If anything, the argument people make for running sermorelin alongside a fat-loss peptide is the opposite of what the Reddit thread worried about: GH pulses support lean mass retention while you are in a calorie deficit, so the pairing is often chosen specifically to protect muscle during aggressive weight loss, not to undermine it.

The part that actually needs fixing: timing

Here is where the real issue lives, and it has nothing to do with weight loss reversing. Sermorelin's half-life is only about 10 to 12 minutes, so the standard advice is to dose it at night, fasted, so the pulse lands on top of your natural overnight GH surge. Food near the dose, especially carbs or fat, blunts the response because of the insulin spike.

On tirzepatide or any GLP-1 receptor agonist, gastric emptying slows down substantially. Food that would normally clear your stomach in about two hours can sit there for closer to three. That means the usual "eat dinner at seven, dose at nine" rule stops being long enough, and residual insulin from dinner ends up suppressing the pituitary right when you wanted the pulse to happen. The fix people have converged on is to move sermorelin to first thing in the morning instead of bedtime, fasted, and eat 30 to 60 minutes after the injection. That single change is the difference between a protocol that works and one that quietly does nothing every night.

You can also pair sermorelin with a ghrelin-receptor agonist like ipamorelin, which hits a separate receptor and adds to the same pulse rather than competing with it. If you are trying to decide whether that second peptide is worth adding on top of an already-running GLP-1 stack, the guide to building a fat-loss peptide stack walks through how people layer these mechanisms without duplicating effort. And if you are weighing sermorelin against a plain GH-axis alternative for a similar goal, the Sermorelin versus Somatropin comparison is worth reading before you add either.

What the dosing actually looks like

Now the part my lawyer makes me say, and he is right: The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

The community-standard adult protocol runs roughly 200 to 300 mcg subcutaneously, about five nights a week, in cycled blocks with periodic breaks so the GHRH receptor stays responsive. A 5 mg vial reconstituted with 2.5 ml of bacteriostatic water gives you 2,000 mcg per ml, so a 300 mcg dose comes out to 0.15 ml, or 15 units on a standard U-100 insulin syringe. On a GLP-1, keep that dose and schedule, just move the clock from bedtime to morning.

The adult evidence for GH-axis benefits like body composition and sleep is extrapolated rather than pulled from a dedicated adult RCT on sermorelin itself. The best adult human data is a retrospective chart review of hypogonadal men where sermorelin was given alongside two other GH secretagogues and raised IGF-1, and a broader review of GH secretagogues in hypogonadal men frames that adult evidence base as still developing. I think that gap is honest rather than damning: the pediatric RCT data proves the mechanism works, and the adult case rests on that mechanism plus established GH-replacement physiology, not on a separate large adult trial that hasn't been run.

What to actually watch for

Side effects reported in the pediatric trials and the long real-world track record from sermorelin's Geref years were generally mild: injection-site reactions, flushing, headache, occasional nausea. I have not seen reports of sermorelin interfering with GLP-1 fat loss in the clients I've worked with, and the mechanism gives no reason to expect it. What I do see, repeatedly, is people running the old bedtime schedule on top of a GLP-1 and wondering why their IGF-1 isn't moving. Fix the timing first before you assume the stack doesn't work.

If you're new to running multiple peptides in the same protocol and want the basics on whether combining compounds is safe in general, Are Peptides Dangerous? is a good starting point before you add anything new to an existing GLP-1 regimen.